Considering the reasons behind the jump in licensing deal values, Chan added: “Licensing agreement deal values for mRNA-based ...

As the COVID virus continues to evolve, experts in respiratory diseases recommend that everyone ages 6 months and older ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

(HealthDay News) — COVID-19 vaccination is associated with a reduced risk for most cardiovascular events, but with slightly increased risks of extrasystoles and transient ischemic attack, as well as ...

Researchers are developing an mRNA vaccine to protect against Clostridioides difficile bacteria, known for causing severe ...

COVID has changed so much from the first few years of the pandemic, when people got those first vaccines in 2021,” said Dr. Doug Pogue, president of BJC Medical Group.

Every week, we bring you a different medical professional to talk about ways for you to stay healthy.This week, we visit with ...

The case of avian influenza A (H5) confirmed by the Centers for Disease Control and Prevention in Missouri, USA, on Sept 6, 2024,1 has reignited concerns about the risk of human contagion and the need ...

We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

Europe’s drug regulator recommended two novel vaccines for influenza alongside updated composition for two COVID-19 vaccines ...